Vor is a biotech company advancing telitacicept, a first- and potentially best-in-class dual BAFF/APRIL inhibitor, to tackle autoimmune disease at its root.
Join Vor in tackling autoimmune disease at its root by advancing telitacicept, a first- and potentially best-in-class dual BAFF/APRIL inhibitor. As a Medical Science Liaison (MSL) in Neurology, you will contribute directly to a medicine with best-in-disease Phase 3 results in myasthenia gravis and expansion into multiple autoimmune diseases.
Vor is a biotech company advancing telitacicept, a first- and potentially best-in-class dual BAFF/APRIL inhibitor, to tackle autoimmune disease at its root.
Vor Bio